FGFR inhibitor gains FDA approval based on 40% response rate in MD Anderson-led Phase II trialCredit: MD Anderson Cancer Center...
Research at St. Jude Children's Research Hospital and Massachusetts General Hospital digs into the cells of origin for key medulloblastoma...
A new way to stop cancer cells from killing their healthy neighbors One of the reasons cancer cells are so...
Credit: Vanderbilt University Cellular soldiers created using the body's own defenses can track down and kill escaping cancer cells during...
Credit: UTSW DALLAS - July 24, 2019 - A new molecular mechanism discovered by UT Southwestern researchers indicates that drugs...
One dose of human papillomavirus (HPV) vaccine has comparable effectiveness to two or three doses for preventing cervical pre-cancer, according...
Findings from 10-country survey reveal lack of information and supportCredit: All.Can International London, 24 July 2019 - People with cancer...
George Mason University patent with applications to breast cancer treatment licensed by Targeted Pharmaceuticals, a cannabinoid-based drug discovery companyCredit: Copyright:...
UT Health San Antonio leads consortium examining loss of DNA repairCredit: UT Health San Antonio Women who inherit harmful mutations...
BOSTON-- A new study from the Massachusetts General Hospital's (MGH) Tobacco Research and Treatment Center provides critical population-level evidence demonstrating...
Researchers at the University of Maryland and National Cancer Institute identified 12 distinct relationships between gene pairs in tumor cells...
Lugano, Switzerland, 23 July 2019 - Participants from all over the world are expected in Barcelona, Spain, between 27 September...
Grants totaling nearly $3.5 million give early career investigators independence to pursue brave and bold cancer research New York, NY...
Testing for genetic weaknesses in repairing DNA could pick out men who may benefit from a new type of targeted...
Credit: UNC Lineberger CHAPEL HILL, North Carolina - Researchers at the UNC Lineberger Comprehensive Cancer Center have discovered a hyperactive...
After a cancer patient receiving an immunotherapy developed encephalitis and died 18 months into treatment, researchers at Vanderbilt-Ingram Cancer Center...
Hot target SIRT2 regulates ribonucleotide reductase The enzyme ribonucleotide reductase is a bottleneck for cancer cell growth. Scientists at Winship...
The incidence of colorectal cancer in adults younger than 50 years of age has increased in the United States since...
Credit: Dan Addison | UVA Health System A young scientist at the University of Virginia School of Medicine has received...
'Embarrassing' or stigmatized cancers like lung and liver are underfundedCredit: Northwestern University Poorly funded cancers: colon, endometrial, liver and bile...
We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.
Bioengineer.org © Copyright 2023 All Rights Reserved.
Bioengineer.org © Copyright 2023 All Rights Reserved.